Irregular Sleep Could Raise Your Odds for Diabetes
By Ernie Mundell HealthDay Reporter
WEDNESDAY, July 17, 2024 (HeathDay News) -- Sleeping long hours one night but only a few hours the next can be unhealthy, with a new study finding "irregular" sleep patterns could be a risk factor for type 2 diabetes.
The results "underscore the importance of consistent sleep patterns as a strategy to reduce type 2 diabetes," said study lead author Sina Kianersi. He's a research fellow in the Channing Division of Network Medicine at Brigham and Women's Hospital in Boston.
The new study involved sleep and health data on more than 84,000 people enrolled in the ongoing UK Biobank Study. The Britons in the study averaged 62 years of age and none had diabetes as the study began.
For seven consecutive nights, the participants wore an accelerometer -- a watch-like device that monitors movement while in bed.
The researchers also tracked whether or not people developed type 2 diabetes over the next 7.5 years.
After adjusting for a bunch of possible confounding factors, Kianersi's team found a clear association between irregular sleep patterns and a heightened risk for type 2 diabetes.
"Irregular" sleep was defined as sleep duration that changed by an average of 60 minutes or more between nights.
Folks with an irregular sleep pattern were 34% more likely to develop type 2 diabetes compared to people whose nightly sleep didn't vary as much.
How might fluctuating sleep duration encourage diabetes?
The study couldn't answer that question, but the Boston team theorize that "circadian disruption and sleep disturbances" could play a role.
The study was published July 17 in Diabetes Care.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-18 01:15
Read more
- Postpartum Exercise Cuts Odds of Postpartum Depression
- Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
- FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency
- Over 40? Get Fitter and Live 5 Extra Years
- President-Elect Trump Nominates Robert F. Kennedy Jr. to Lead HHS
- Antiviral Treatment Underutilized for Children, Teens With Flu
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions